Data is not available at this time.
NorthWest Healthcare Properties REIT operates as a specialized real estate investment trust focused on high-quality healthcare infrastructure across Canada, Brazil, Europe, Australia, and New Zealand. Its portfolio includes medical office buildings, clinics, and hospitals, characterized by long-term, inflation-indexed leases with stable occupancy rates. The REIT serves as a strategic real estate partner to leading healthcare operators, leveraging its fully integrated management team across nine offices in five countries to optimize asset performance and tenant relationships. NorthWest's diversified geographic footprint and focus on essential healthcare real estate provide resilience against economic cycles, while its emphasis on long-duration leases ensures predictable cash flows. The REIT's competitive advantage lies in its deep sector expertise, international scale, and ability to align with healthcare operators' needs, positioning it as a key player in the global healthcare real estate market.
NorthWest reported revenue of CAD 462.4 million for the period, reflecting its stable lease-based income model. However, the REIT posted a net loss of CAD 299.8 million, with diluted EPS of -CAD 1.21, indicating significant financial pressures. Operating cash flow stood at CAD 86.6 million, while capital expenditures were minimal at CAD -0.9 million, suggesting a focus on maintaining rather than expanding its current asset base.
The REIT's negative earnings highlight challenges in its current operational and financial structure. With a market capitalization of CAD 1.17 billion and a beta of 1.216, NorthWest exhibits higher volatility than the broader market. The modest operating cash flow relative to its debt load raises questions about its ability to service obligations while maintaining dividend payouts.
NorthWest's balance sheet shows CAD 51.2 million in cash against total debt of CAD 3.01 billion, indicating a highly leveraged position. This substantial debt burden, coupled with recent net losses, may constrain financial flexibility. The REIT's asset-heavy model provides collateral but also requires careful management of refinancing risks and interest rate exposure.
Despite financial challenges, NorthWest maintains a dividend yield with CAD 0.36 per share distributed. The REIT's growth prospects depend on its ability to stabilize earnings, manage debt, and potentially capitalize on global healthcare real estate demand. Its international diversification could provide opportunities, but current financial performance suggests a cautious approach to expansion.
The market values NorthWest at approximately 2.5 times revenue, reflecting both the stability of healthcare real estate and concerns about its profitability. Investors appear to be pricing in expectations for operational improvements and potential asset sales to address the REIT's financial challenges while maintaining its income-oriented appeal.
NorthWest's strategic advantages include its specialized healthcare focus, international diversification, and long-term lease structure. However, its outlook depends on improving operational efficiency, reducing leverage, and navigating global real estate market conditions. The essential nature of healthcare real estate provides a defensive position, but execution risks remain elevated given current financial pressures.
Company description, financial data from TSX filings
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |